Concomitant acute limb ischemia and myocardial infarction: another challenge of COVID-19's hypercoagulability.
Ouissal Aissaoui, Salem Husam, Anass Mounir, El Ghali Benouna, Othmane Benmallem, Chafik El Kettani, Lahoucine Barrou
Author Information
Ouissal Aissaoui: Department of Intensive Care and Anesthesiology, Ibn Rochd University Hospital, Laboratory of Clinical Immunology, Inflammation and Allergy (LICIA), Hassan II University of Casablanca Morocco.
Salem Husam: Department of Intensive Care and Anesthesiology, Ibn Rochd University Hospital, Laboratory of Clinical Immunology, Inflammation and Allergy (LICIA), Hassan II University of Casablanca Morocco.
Anass Mounir: Department of Intensive Care and Anesthesiology, Ibn Rochd University Hospital, Laboratory of Clinical Immunology, Inflammation and Allergy (LICIA), Hassan II University of Casablanca Morocco.
El Ghali Benouna: Department of Cardiology, Ibn Rochd University Hospital, Hassan II University of Casablanca Morocco.
Othmane Benmallem: Department of Cardiology, Ibn Rochd University Hospital, Hassan II University of Casablanca Morocco.
Chafik El Kettani: Department of Intensive Care and Anesthesiology, Ibn Rochd University Hospital, Laboratory of Clinical Immunology, Inflammation and Allergy (LICIA), Hassan II University of Casablanca Morocco.
Lahoucine Barrou: Department of Intensive Care and Anesthesiology, Ibn Rochd University Hospital, Laboratory of Clinical Immunology, Inflammation and Allergy (LICIA), Hassan II University of Casablanca Morocco.
The COVID-19, actual pandemic due to SARS COV 2 is associated with numerous thromboembolic complications. Although venous thrombosis including pulmonary embolisms have been widely described, arterial localization seems rarely reported. Acute limb ischemia and myocardial infarction are two major consequences of arterial thrombosis and their concomitant occurrence among COVID-19 patients is extremely rare. It is an evident aspect of hypercoagulability and a real challenge to physicians. We herein describe the management of a 77 years old COVID-19 patient presenting an acute lower limb ischemia with concomitant myocardial infarction. He underwent coronary angiography with subsequent stent placement then was transferred to the operating room where a thrombectomy was performed. The outcome was poor as the cardiogenic shock persisted in addition to a reperfusion syndrome with multiorgan failure.
